The report provides a detailed analysis essential for establishing a mesembrenol production plant. It encompasses all critical aspects necessary for mesembrenol production, including the cost of mesembrenol production, mesembrenol plant cost, mesembrenol production costs, and the overall mesembrenol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a mesembrenol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Mesembrenol is a naturally occurring alkaloid from Sceletium tortuosum plants. It is mainly utilised in the pharmaceutical industry due to its potent PDE-4 inhibition and serotonin reuptake inhibition properties. It is used in medications and dietary supplements to treat conditions like asthma, COPD, anxiety, depression, arthritis, and neurodegenerative diseases. It functions as a major building block for organic synthesis and the development of new materials with targeted pharmacological profiles. It also supports quality control processes for raw materials derived from Sceletium extracts to ensure production consistency. Additionally, it finds potential in forensic analysis of plant-based products and emerging therapeutic areas such as anti-epileptic treatments, though broad non-pharmaceutical industrial uses remain limited.
Mesembrenol's market growth is driven by the rising demand for natural alkaloids in the pharmaceutical sector, fuelled by consumer interest in plant-based therapies for mental health conditions like anxiety, depression, and cognitive impairment, as derived from Sceletium tortuosum extracts.
The growing regulatory acceptance of herbal supplements and phyto-pharmaceuticals, along with patents for its PDE-4 and serotonin reuptake inhibition applications in treating asthma, COPD, and neurodegenerative diseases, boosts commercial production and quality control needs. The expansion in the global herbal products market, coupled with research into standardised extracts and forensic analysis for product authenticity, further propels supply chain investments. However, limited natural sourcing from South African plant cultivation creates supply variability, compounded by challenges in scalable extraction and standardisation of chemotype-specific content, driving up costs and necessitating quality control, which impacts industrial mesembrenol procurement.
Raw Material for Mesembrenol Production
According to the mesembrenol production plant project report, the raw material for mesembrenol production includes mesembrenone.
Production Process of Mesembrenol
The extensive mesembrenol production cost report consists of the following major industrial production process:
- Production via stereoselective Mizoroki-Heck reduction process: The production process of mesembrenol involves stereoselective reduction of mesembrenone, a key precursor derived from Sceletium tortuosum extracts or total synthesis. The process utilises catalytic hydrogenation (e.g., Pd/C) or metal hydride reagents like NaBH4 under controlled conditions to form the cis-3a-aryloctahydroindole alcohol with high diastereoselectivity. The mesembrenone core is constructed via palladium-catalysed intramolecular Mizoroki-Heck reactions on aryl halide substrates to establish the quaternary benzylic C-3a centre, followed by Buchwald-type cross-couplings of cyclohexenones with aryl bromides, and optional Wittig-Claisen sequences for bicyclic assembly. Post-reduction, the product is purified by silica gel chromatography or RP-HPLC, achieving reported yields of 60–90% under optimised laboratory or pilot-scale conditions, with purification validated by GC-MS or UHPLC.
Properties of Mesembrenol
Mesembrenol is a chiral alkaloid with the molecular formula C17H23NO3 and a molecular weight of 289.4 g/mol. It consists of an aryloctahydroindole skeleton originally derived from Sceletium tortuosum plants. It exists as a white to off-white crystalline solid, soluble in organic solvents like ethanol and methanol, with computed lipophilicity indicated by an XLogP3-AA value reflecting moderate hydrophobicity suitable for biological activity. It possesses stereospecific protonation at the C-7 position during biosynthesis, which contributes to its pharmacological properties such as PDE-4 inhibition and serotonin reuptake inhibition. It has a binding affinity (Ki) of 63 nM to the serotonin transporter.